Loading Calculator...
Please wait a moment
Please wait a moment
Assess your menopause stage based on age, menstrual history, symptoms, and FSH levels
Menopause is a natural biological process marking the end of menstruation and reproductive years. This calculator helps assess your current stage based on multiple factors including age, time since last period, symptoms, and optional FSH (follicle-stimulating hormone) testing.
The menopausal transition typically occurs between ages 45-55, with the average age being 51. However, timing varies significantly among individuals due to genetics, lifestyle factors, medical conditions, and treatments. Understanding your stage can help guide appropriate symptom management and preventive health measures.
FSH testing provides additional confirmation of menopausal status. As ovarian function declines, FSH levels rise in an attempt to stimulate the ovaries. However, FSH levels can fluctuate during perimenopause, so a single measurement may not be definitive. Clinical diagnosis primarily relies on menstrual history and symptoms.
HRT is the most effective treatment for menopausal symptoms, particularly hot flashes and vaginal dryness. Systemic estrogen therapy (with progestin for women with a uterus) can significantly improve quality of life. Benefits must be weighed against potential risks, particularly for cardiovascular disease and breast cancer in certain populations.
For women who cannot or prefer not to use hormone therapy, options include SSRIs/SNRIs for hot flashes, gabapentin, clonidine, and cognitive behavioral therapy. Vaginal moisturizers and lubricants can help with genitourinary symptoms.
Regular exercise, healthy diet, stress management, adequate sleep, avoiding triggers (caffeine, alcohol, spicy foods), and maintaining a healthy weight can all help manage symptoms. Weight-bearing exercise and calcium/vitamin D supplementation support bone health.
After menopause, decreased estrogen levels affect multiple body systems. Bone density decreases more rapidly, increasing osteoporosis risk. Cardiovascular disease risk increases, making heart-healthy lifestyle choices crucial. Genitourinary symptoms can affect quality of life and require ongoing management.
Postmenopausal women should prioritize bone density screening (DEXA scans), cardiovascular health monitoring, and age-appropriate cancer screenings (mammograms, colonoscopy, cervical cancer screening per guidelines). Maintaining muscle mass through resistance training and adequate protein intake becomes increasingly important.
Women experiencing premature or early menopause face additional health risks due to longer duration of estrogen deficiency. These women should be evaluated for underlying causes and typically require hormone therapy at least until the average age of menopause to reduce long-term health risks.
In women over 45 with typical symptoms and menstrual changes, clinical diagnosis is usually sufficient without laboratory testing. FSH testing is most useful for confirming menopause in younger women (under 45) or when diagnosis is unclear. However, FSH levels fluctuate during perimenopause, so clinical history remains primary.
Yes, pregnancy is possible during perimenopause as long as you're still having periods, even if irregular. Contraception should be continued until you've been without periods for 12 consecutive months if over 50, or 24 months if under 50. Discuss appropriate contraceptive options with your healthcare provider.
Premature menopause (before age 40) can result from genetic factors, autoimmune conditions, chemotherapy or radiation, surgical removal of ovaries, or may be idiopathic. Women with premature menopause require comprehensive evaluation and typically need hormone therapy until at least age 51 to reduce health risks.
Vasomotor symptoms (hot flashes and night sweats) typically peak during perimenopause and early postmenopause, lasting an average of 7-10 years but varying widely among individuals. Some women experience symptoms for just months, while others have symptoms for 10+ years. Vaginal and urinary symptoms tend to persist or worsen without treatment.
HRT safety depends on individual factors including age, time since menopause, personal and family medical history, and type/dose of hormones used. For most healthy women under 60 or within 10 years of menopause, benefits typically outweigh risks. However, HRT isn't appropriate for everyone. Discuss risks and benefits with your healthcare provider to make an informed decision.
FSH is the primary blood test used, with levels >30-40 mIU/mL suggesting menopause. However, FSH fluctuates during perimenopause, so a single test may not be definitive. Estradiol levels may also be checked (low levels support menopause). For most women over 45 with typical symptoms, testing isn't necessary for diagnosis.
Menopause itself doesn't directly cause weight gain, but hormonal changes, aging, lifestyle factors, and decreased muscle mass all contribute to weight gain around menopause. The distribution of fat shifts toward abdominal/visceral fat, increasing metabolic and cardiovascular risks. Regular exercise, strength training, and dietary modifications can help manage weight during this transition.
"Bioidentical" hormones have the same molecular structure as hormones produced by the body. FDA-approved bioidentical hormones (like estradiol and micronized progesterone) are appropriate options for HRT. However, compounded bioidentical hormones lack FDA oversight and standardized dosing, and aren't proven safer than FDA-approved options. Discuss evidence-based hormone therapy options with your provider.